We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Palopegteriparatide improved skeletal dynamics and renal ...

Researchers successfully developed and validated a new outcome measure to monitor disease severity and progression in patients with impaired skeletal muscle function caused by mitochondrial disease.

From arthritis and heart failure to diabetes and menopause, many conditions are associated with muscle weakness and increased fat deposits. Now a multidisciplinary team of researchers at the ...